MedTrace Logo

Quantifying Patient-Specific Changes in Neuromuscular Control in Cerebral Palsy

NCT02699554 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 55

Last updated 2022-05-09

Study results available
· View outcomes & findings →

Summary

Impaired neuromuscular control hinders movement for individuals with cerebral palsy and other neurological disorders. In this research, the investigators are developing new tools to quantify impaired neuromuscular control in cerebral palsy and evaluate changes after one of the most common treatments, orthopaedic surgery. The results from this research will empower clinicians to identify patient-specific factors that contribute to impaired movement and improve treatment and quality of life.

Conditions

  • Cerebral Palsy

Interventions

PROCEDURE

Single-event multilevel surgery

Sponsors & Collaborators

  • National Institute of Neurological Disorders and Stroke (NINDS)

    collaborator NIH

  • Gillette Children's Specialty Healthcare

    collaborator OTHER

  • University of Washington

    lead OTHER

Principal Investigators

  • Katherine M Steele, PhD · University of Washington

Eligibility

Min Age
6 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-09-30
Primary Completion
2020-09-30
Completion
2020-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02699554 on ClinicalTrials.gov